Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
A clinical trial update describes a study evaluating microRNA as a diagnostic, prognostic, and treatment-response biomarker in pancreatic ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial evaluating adding Peposertib (M3814) to radiotherapy for locally advanced pancreatic cancer is currently recruiting (Phase 1/…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer [Phase 1]
A Phase 1 trial is evaluating the safety of combining durvalumab and olaparib with radiation therapy in locally advanced unresectable pancre…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
This clinical trial update describes a pancreatic cancer screening study for individuals with new-onset or deteriorating diabetes mellitus, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]
Phase 1 clinical trial update on QXL138AM assessing safety, pharmacokinetics, and preliminary efficacy in patients with solid tumors and mul…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) [Phase 2]
This Phase 2 MATCH Screening Trial update describes ongoing evaluation of targeted therapies matched to genetic alterations in patients with…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer [Phase 2]
Phase 2 PaTcH trial of trametinib plus hydroxychloroquine in metastatic pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating chemotherapy with or without INCB161734 in untreated metastatic pancreatic ductal adenocarcinoma with KR…
-
CLINICAL_TRIALS other · 2026-04-13Clinical Trial Update: Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Entinostat in combination with ZEN003694 for advanced solid tumors, including locally advanced and metas…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent [NA]
The update describes a trial evaluating multimedia-based consent for pancreatic cancer surgery, sponsored by UNC Lineberger Comprehensive Ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating the combination of gemcitabine hydrochloride, dasatinib, and erlotinib hydrochloride in patients with metastatic or…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating GDC-0449 (vismodegib) and erlotinib hydrochloride, with or without gemcitabine hydrochloride, in metastatic pancrea…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This is a Phase 1 trial updating the safety and dosing of M6620 in combination with irinotecan in patients with metastatic or unresectable s…
-
CLINICAL_TRIALS withdrawal · 2026-04-13Clinical Trial Update: Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle [NA]
A clinical trial comparing Beacon BNX EUS-Needle vs SharkCore Needle has been withdrawn. The study involved pancreatic cancer, lymphadenopat…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors [Phase 2]
A Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-expressing tumors, including bladder, biliary tract, cervical, …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors [Phase 2]
Phase 2 study evaluating futibatinib in combination with a PD-1 antibody-based standard of care for locally advanced unresectable or metasta…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers [Phase 1]
Phase Ib trial evaluating adagrasib (KRAS G12C inhibitor) in combination with olaparib in KRAS G12C-mutated advanced solid tumors, focusing …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer [Phase 3]
A Phase 3 trial is evaluating higher-dose radiation therapy for locally advanced unresectable pancreatic ductal adenocarcinoma, and recruitm…